Extendicare Inc. (TSE:EXE – Get Free Report)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$10.12 and traded as high as C$13.35. Extendicare shares last traded at C$13.06, with a volume of 305,519 shares.
Wall Street Analysts Forecast Growth
EXE has been the subject of several recent research reports. TD Securities boosted their price target on shares of Extendicare from C$10.50 to C$13.00 and gave the company a “hold” rating in a report on Monday, March 3rd. BMO Capital Markets boosted their price objective on shares of Extendicare from C$11.00 to C$13.50 in a research note on Monday, March 3rd. Cormark upgraded Extendicare to a “moderate buy” rating in a report on Wednesday, February 19th. Finally, Royal Bank of Canada lifted their price target on Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a report on Thursday, November 28th.
Read Our Latest Stock Report on EXE
Extendicare Stock Up 0.5 %
Extendicare Dividend Announcement
The firm also recently declared a monthly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 17th were given a dividend of $0.04 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.68%. The ex-dividend date of this dividend was Friday, February 28th. Extendicare’s payout ratio is presently 61.20%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Read More
- Five stocks we like better than Extendicare
- Market Cap Calculator: How to Calculate Market Cap
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What is MarketRank™? How to Use it
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How to Calculate Inflation Rate
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.